Copyright
©The Author(s) 2025.
World J Gastrointest Oncol. Feb 15, 2025; 17(2): 97858
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.97858
Published online Feb 15, 2025. doi: 10.4251/wjgo.v17.i2.97858
Figure 7 Colony-stimulating factor/colony-stimulating factor 3 receptor regulates the expression of leukocyte immunoglobulin-like receptor B2, angiopoietin-like protein 2, and human leukocyte antigen-G through heterogeneous nuclear ribonucleoprotein H1.
A-C: The mRNA expression levels when heterogeneous nuclear ribonucleoprotein H1 (hnRNPH1) expression is downregulated or upregulated; D: Protein expression levels when hnRNPH1 expression is downregulated or upregulated; E-G: The mRNA expression levels when hnRNPH1 expression is downregulated with or without colony-stimulating factor 3 stimulation; H: Protein expression levels when hnRNPH1 expression is downregulated with or without colony-stimulating factor 3 stimulation. aP < 0.0001; bP < 0.001; cP < 0.01; dP < 0.05. LILRB2: Leukocyte immunoglobulin-like receptor B2; ANGPTL2: Angiopoietin-like protein 2; HLA-G: Human leukocyte antigen-G; hnRNPH1: heterogeneous nuclear ribonucleoprotein H1; CSF3R: Colony-stimulating factor 3 receptor.
- Citation: Wang L, Wu Q, Zhang ZW, Zhang H, Jin H, Zhou XL, Liu JY, Li D, Liu Y, Fan ZS. Colony-stimulating factor 3 and its receptor promote leukocyte immunoglobulin-like receptor B2 expression and ligands in gastric cancer. World J Gastrointest Oncol 2025; 17(2): 97858
- URL: https://www.wjgnet.com/1948-5204/full/v17/i2/97858.htm
- DOI: https://dx.doi.org/10.4251/wjgo.v17.i2.97858